DBD — Diebold Nixdorf Income Statement
0.000.00%
Last trade - 00:00- $2.51bn
- $3.06bn
- $3.81bn
Annual income statement for Diebold Nixdorf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3,905 | 3,461 | 3,761 | 3,751 | 3,806 |
| Cost of Revenue | |||||
| Gross Profit | 1,059 | 778 | 876 | 948 | 1,003 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3,768 | 3,705 | 2,077 | 3,576 | 3,564 |
| Operating Profit | 137 | -244 | 1,684 | 175 | 242 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -50.7 | -439 | 1,448 | 47.3 | 125 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -78.4 | -588 | 1,373 | -17 | 101 |
| Minority Interest | |||||
| Equity in Affiliates | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -78.8 | -581 | 1,376 | -16.5 | 94.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -78.8 | -581 | 1,376 | -16.5 | 94.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.736 | -5.2 | 10.1 | 1.5 | 4.55 |
| Dividends per Share |